G01N 2440/38
Addition of carbohydrates
Official title: addition of carbohydrates, e.g. glycosylation, glycation
G01N2440/38 (Addition of carbohydrates) appears on 158 US grants and 349 published applications in this corpus.
Search patents in G01N- Granted patents
- 158
- Published applications
- 349
- Assignees
- 193
- Inventors
- 722
- Latest grant
- 15 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2004 | 0 | 1 |
| 2005 | 0 | 1 |
| 2006 | 0 | 2 |
| 2007 | 0 | 0 |
| 2008 | 0 | 2 |
| 2009 | 2 | 3 |
| 2010 | 0 | 6 |
| 2011 | 2 | 6 |
| 2012 | 3 | 9 |
| 2013 | 9 | 9 |
| 2014 | 7 | 19 |
| 2015 | 7 | 26 |
| 2016 | 9 | 30 |
| 2017 | 7 | 23 |
| 2018 | 20 | 27 |
| 2019 | 13 | 23 |
| 2020 | 16 | 22 |
| 2021 | 14 | 24 |
| 2022 | 13 | 19 |
| 2023 | 10 | 22 |
| 2024 | 10 | 32 |
| 2025 | 10 | 25 |
| 2026 | 6 | 18 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Target-based method for high-throughput and subclass specific IgG glycan profiling in human plasma15 Sep 2026US 12,736,541 B2Regeneron Pharmaceuticals, Inc.
- Biomarkers for clear cell renal cell carcinoma2 Jun 2026US 12,644,892 B2Venn Biosciences Corporation
- Systems and methods for glycopeptide concentration determination, normalized abundance determination, and LC/MS run sample preparation17 Mar 2026US 12,578,346 B2Venn Biosciences Corporation
- Methods of diagnosing or treating Lyme disease3 Mar 2026US 12,566,180 B2Drexel University
- Affinity chromatography-coupled native mass spectrometry for antibody analysis27 Jan 2026US 12,535,490 B2Regeneron Pharmaceuticals, Inc.
- Combination therapy of polio virus receptor inhibitors and fucose8 Oct 2026US 2026/0309713 A1H. Lee Moffitt Cancer Center and Research Institute, Inc.
- Glycated protein assay reagent containing stabilizer of protease that increases oxidation-reduction potential of ferrocyanide, method for assaying glycated protein, method for preserving glycated protein assay reagent, and method for stabilizing glycated protein assay reagent10 Sep 2026US 2026/0266832 A1Nagase Diagnostics Co., Ltd.
- Targeting aberrant o-glycans of iga1 to develop a urinary diagnostic method for iga nephropathy3 Sep 2026US 2026/0259209 A1Buddhist Tzu Chi Medical Foundation
- Diagnosis of pancreatic cancer using targeted quantification of site-specific protein glycosylation27 Aug 2026US 2026/0253677 A1
- Methods of diagnosing or treating lyme disease20 Aug 2026US 2026/0243778 A1Drexel University
Most cited
By later US patents
- Methods of cell culture59US 9,217,168 B2Momenta Pharmaceuticals, Inc. · 2015
- Methods of cell culture51US 9,663,810 B2Momenta Pharmaceuticals, Inc. · 2017
- Methods of cell culture30US 10,144,944 B2Momenta Pharmaceuticals, Inc. · 2018
- Methods for identifying compounds for the treatment of type 1 diabetes20US 8,030,288 B2BioCrine AB · 2011
- Multi-dimensional chromatographic methods for separating N-glycans20US 8,304,250 B2Momenta Pharmaceuticals, Inc. · 2012